Emerging Cancer Diagnostic Markets Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Emerging Cancer Diagnostic Markets size is expected to grow at an annual average of 7% during 2021-2027. Cancer diagnosis is a method of identifying various biomarkers, proteins, and some signs that identify the presence of cancerous tumors. Efficient diagnostic tests are used to verify or rule out the presence of disease, monitor disease progression, and schedule and review treatment outcomes. Cancer diagnostic procedures may include imaging tests, tumor biopsies, laboratory tests (including tests for tumor markers), endoscopy, surgery, or genetic testing.

The following segmentation are covered in this report:

By End-use

• Hospitals
• Diagnostic laboratories
• Diagnostic imaging centers
• Cancer research institutes

By Cancer type

• Bladder cancer
• Breast cancer
• Colon and rectal cancer
• Endometrial cancer
• Kidney cancer
• Leukemia
• Liver-lung cancer
• Melanoma
• Non-Hodgkin lymphoma
• Pancreatic cancer
• Prostate cancer
• Thyroid cancer
• Others

Company Profile

• Abbott Laboratories
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Roche Holdings AG (F. Hoffmann-La Roche Ltd.)
• Danaher Corporation (GE Healthcare)
• Hologic, Inc.
• Koninklijke Philips N.V. (Philips Healthcare)
• Qiagen N.V.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.

Scope of the report

The research study analyses the Emerging Cancer Diagnostic Markets industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Emerging Cancer Diagnostic Markets Report

• What was the Emerging Cancer Diagnostic Markets size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Emerging Cancer Diagnostic Markets was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.